Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
Recruiting now · Not applicable
Conditions studied: Cervical Cancer
In brief
The purpose of the study is to find out if a self-administered (by the patient) Papanicolaou (Pap) smear is as accurate as a traditional Pap smear administered by a healthcare provider.
Key facts
- Study ID
- NCT04093388
- Run by
- University of Alabama at Birmingham
- People needed
- 250
- Starts
- 2021-04-26
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2026-03-31
Who can join
Age: 21 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female of at least 21 years of age and not over 65 presenting who need routine cervical cancer screening per national guidelines.
You may not qualify if…
- prior history of cervical cancer or a positive Pap smear, have had a total hysterectomy (removal of uterus and cervix), or currently enrolled in any other cancer prevention study.
Where it is running
- Cahaba Medical Care - West End — Birmingham, Alabama, United States (enrolling)
- Cahaba Medical Care - Ensley — Birmingham, Alabama, United States (enrolling)
- Cahaba Medical Care — Centreville, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.